Related Experiment Video
Updated: Aug 6, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual
Kenneth S Gunasekera1, Olivier Marcy2, Johanna Muñoz3
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Insights
New algorithms improve diagnosis of childhood tuberculosis (TB). These evidence-based tools aid treatment decisions in primary care, aiming to reduce mortality in high-incidence areas.
Area of Science:
- Global Health
- Infectious Diseases
- Pediatrics
Background:
- Pulmonary tuberculosis (TB) in children often goes undiagnosed, leading to high morbidity and mortality.
- Existing diagnostic algorithms for childhood TB are limited in generalizability.
- There is a need for improved, evidence-based algorithms for TB treatment decisions in primary care settings.
Approach:
- A meta-analysis of individual participant data from 13 studies across 12 high-TB-incidence countries was conducted.
- Two multivariable prediction models were developed: one including chest X-ray features and one using only clinical features.
- These models were used to create pragmatic, evidence-based treatment-decision algorithms for primary healthcare.
Key Points:
- Existing algorithms showed variable diagnostic performance.
- The model incorporating clinical and chest X-ray features achieved a sensitivity of 0.86 and specificity of 0.37.
- The model using only clinical features had a sensitivity of 0.84 and specificity of 0.30.
Conclusions:
- Developed algorithms empower healthcare workers to initiate TB treatment in children, improving access to care.
- These algorithms are designed for primary care settings in high-incidence areas, regardless of resource availability.
- The algorithms aim to reduce childhood TB-related mortality and have been incorporated into WHO guidelines.
Background:
Many children with pulmonary tuberculosis remain undiagnosed and untreated with related high morbidity and mortality. Recent advances in childhood tuberculosis algorithm development have incorporated prediction modelling, but studies so far have been small and localised, with limited generalisability. We aimed to evaluate the performance of currently used diagnostic algorithms and to use prediction modelling to develop evidence-based algorithms to assist in tuberculosis treatment decision making for children presenting to primary health-care centres.
Methods:
For this meta-analysis, we identified individual participant data from a WHO public call for data on the management of tuberculosis in children and adolescents and referral from childhood tuberculosis experts. We included studies that prospectively recruited consecutive participants younger than 10 years attending health-care centres in countries with a high tuberculosis incidence for clinical evaluation of pulmonary tuberculosis. We collated individual participant data including clinical, bacteriological, and radiological information and a standardised reference classification of pulmonary tuberculosis. Using this dataset, we first retrospectively evaluated the performance of several existing treatment-decision algorithms. We then used the data to develop two multivariable prediction models that included features used in clinical evaluation of pulmonary tuberculosis-one with chest x-ray features and one without-and we investigated each model's generalisability using internal-external cross-validation. The parameter coefficient estimates of the two models were scaled into two scoring systems to classify tuberculosis with a prespecified sensitivity target. The two scoring systems were used to develop two pragmatic, treatment-decision algorithms for use in primary health-care settings.
Findings:
Of 4718 children from 13 studies from 12 countries, 1811 (38·4%) were classified as having pulmonary tuberculosis: 541 (29·9%) bacteriologically confirmed and 1270 (70·1%) unconfirmed. Existing treatment-decision algorithms had highly variable diagnostic performance. The scoring system derived from the prediction model that included clinical features and features from chest x-ray had a combined sensitivity of 0·86 [95% CI 0·68-0·94] and specificity of 0·37 [0·15-0·66] against a composite reference standard. The scoring system derived from the model that included only clinical features had a combined sensitivity of 0·84 [95% CI 0·66-0·93] and specificity of 0·30 [0·13-0·56] against a composite reference standard. The scoring system from each model was placed after triage steps, including assessment of illness acuity and risk of poor tuberculosis-related outcomes, to develop treatment-decision algorithms.
Interpretation:
We adopted an evidence-based approach to develop pragmatic algorithms to guide tuberculosis treatment decisions in children, irrespective of the resources locally available. This approach will empower health workers in primary health-care settings with high tuberculosis incidence and limited resources to initiate tuberculosis treatment in children to improve access to care and reduce tuberculosis-related mortality. These algorithms have been included in the operational handbook accompanying the latest WHO guidelines on the management of tuberculosis in children and adolescents. Future prospective evaluation of algorithms, including those developed in this work, is necessary to investigate clinical performance.
Funding:
WHO, US National Institutes of Health.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Analysis of Population Pharmacokinetic Data

